Allogeneic bone marrow transplantation involves the transfer of marrow from a donor to another person. The donor and recipient may be:
The oldest age for allogeneic transplantation is usually considered to be 40 to 55 years. Increasing age is associated with poorer results due to a higher frequency of graft versus host disease. T cells may be removed from the graft to ameliorate the manifestations of GVHD.
Donation involves the aspiration of about 1L of bone marrow. The recipient is given high dose ablative chemotherapy and, in all but those with aplastic anaemia, total body irradiation. The goals are to:
The donor marrow cells are infused intravenously and localise in the marrow. The peripheral blood count rises within 2-4 weeks.
The results of allogeneic transplant undertaken in first complete remission are much better than those in relapse.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page